Nuveen, LLC Agios Pharmaceuticals, Inc. Put Options Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
244Shares Held
58.7MCall Options Held
300KPut Options Held
362K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$170 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$146 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$105 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$72.6 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.64B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...